SONNET BIOTHERAPEUTICS HOLDI (SONN) Stock Analyst Earnings Estimates
NASDAQ:SONN - Nasdaq - US83548R4020 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 350K -27.08% | 147.81K -57.77% | 18.63K -87.40% | -100.00% | 10.2M | 32.844M 222.00% | 64.056M 95.03% | 98.94M 54.46% | |||
| EBITDA YoY % growth | -29.66M -18.26% | -18.78M 36.68% | -11.837M 36.97% | -46.206M -290.36% | -53.04M -14.79% | -61.2M -15.38% | -59.67M 2.50% | -46.92M 21.37% | -25.602M 45.43% | N/A | |
| EBIT YoY % growth | -29.67M -18.25% | -18.793M 36.66% | -11.849M 36.95% | 14.802M 224.92% | -54.876M -470.73% | -37.74M 31.23% | -35.598M 5.68% | -34.068M 4.30% | -19.89M 41.62% | 7.14M 135.90% | |
| Operating Margin | -8,477.14% | -12,714.03% | -63,604.24% | N/A | N/A | N/A | -349.00% | -103.73% | -31.05% | 7.22% | |
| EPS YoY % growth | -1,205.60 53.88% | -240.24 80.07% | N/A 94.53% | -15.26 -16.15% | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -5.60 75.52% | -6.24 | 0.64 | 10.29% |
| Q2 2024 Q2Q % growth | 0.56 100.94% | 1.10 | -0.54 | -49.16% |
| Q1 2024 Q2Q % growth | -2.48 98.24% | -7.34 | 4.86 | 66.23% |
| Q4 2023 Q2Q % growth | -16.72 94.31% | -33.40 | 16.68 | 49.94% |
| Q3 2023 Q2Q % growth | -22.88 92.86% | -55.65 | 32.77 | 58.89% |
| Q2 2023 Q2Q % growth | -59.84 82.65% | -88.86 | 29.02 | 32.66% |
| Q1 2023 Q2Q % growth | -140.80 42.86% | -197.47 | 56.67 | 28.70% |
| Q4 2022 Q2Q % growth | -293.92 31.84% | -271.08 | -22.84 | -8.43% |
| Q3 2022 Q2Q % growth | -320.32 -118,537.04% | -351.86 | 31.54 | 8.96% |
| Q2 2022 Q2Q % growth | -344.96 | -301.59 | -43.37 | -14.38% |
| Q1 2022 Q2Q % growth | -246.40 -72,370.59% | -477.52 | 231.12 | 48.40% |
| Q4 2021 Q2Q % growth | -431.20 | -552.92 | 121.72 | 22.01% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -100.00% | 29.07K | -29.07K | -100.00% |
| Q2 2024 Q2Q % growth | -100.00% | 12.577K | -12.577K | -100.00% |
| Q1 2024 Q2Q % growth | 18.63K -53.43% | 18.36K | 270 | 1.47% |
| Q4 2023 Q2Q % growth | 37.26K -37.90% | 19.043K | 18.217K | 95.66% |
| Q3 2023 Q2Q % growth | 37K -38.33% | 37K | % | |
| Q2 2023 Q2Q % growth | 36.45K -63.55% | 36.45K | % | |
| Q1 2023 Q2Q % growth | 40K -69.23% | 102K | -62K | -60.78% |
| Q4 2022 Q2Q % growth | 60K -87.50% | 102K | -42K | -41.18% |
| Q3 2022 Q2Q % growth | 60K | 51K | 9K | 17.65% |
| Q2 2022 Q2Q % growth | 100K | 51K | 49K | 96.08% |
| Q2 2021 Q2Q % growth | -100.00% | % | ||
| Q1 2021 Q2Q % growth | -100.00% | % | ||
| Q4 2020 Q2Q % growth | -100.00% | % | ||
| Q3 2020 Q2Q % growth | -100.00% | % | ||
| Q2 2020 Q2Q % growth | 5.68M -27.55% | % | ||
| Q1 2020 Q2Q % growth | 1.94M 708.33% | % | ||
| Q2 2019 Q2Q % growth | 7.84M | 11.318M | -3.478M | -30.73% |
| Q1 2019 Q2Q % growth | 240K | 10.512M | -10.272M | -97.72% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | -700% |
| Revenue | N/A | N/A | N/A | N/A |